0

Treatment of Recurrent Herpes Simplex Infections With L-lysine Monohydrochloride

M A McCune, H O Perry, S A Muller, W M O'Fallon

Cutis. 1984 Oct;34(4):366-73.

PMID: 6435961

Abstract:

In a prospective, randomized, double-blind, placebo-controlled, cross-over study of forty-one patients we found that oral ingestion of 1,248 mg a day of L-Lysine monohydrochloride shows evidence of decreasing the recurrence rate of herpes simplex attacks in nonimmunocompromised hosts. A dose of 624 mg a day was not effective. L-Lysine may also be capable of decreasing the severity of symptoms associated with recurrences. Neither dosage showed any evidence of shortening the healing time compared to placebo.

Chemicals Related in the Paper:

Catalog Number Product Name Structure CAS Number Price
AP657272-A L-Lysine monohydrochloride L-Lysine monohydrochloride 657-27-2 Price
qrcode